Urinalysis Test Market By Product (Instruments, Consumables), By Application (Disease screening, Pregnancy and fertility), By End user (Hospitals and clinics, Diagnostic laboratories, Home care): Global Opportunity Analysis and Industry Forecast, 2021-2031
The urinalysis test market size valued for $3,194.13 million in 2021 and is estimated to reach $6,121.35 million by 2031, exhibiting a CAGR of 6.7% from 2022 to 2031.
A urinalysis is a common test that uses a urine sample to evaluate a wide variety of urine contents. Urinalysis is a test that examines the appearance, composition, and content of urine. It is a common diagnostic tool used to detect various health conditions such as urinary tract infections, kidney problems, liver problems, diabetes, and pregnancy. A urine sample is collected and sent to a laboratory for analysis during a urinalysis test. The sample is usually collected in a sterile container and obtained through a clean catch method, which involves collecting the midstream portion of urine, through a catheter.
The global urinalysis test market is majorly driven by an increase in the incidences of chronic diseases such as chronic kidney disease, urinary tract infections, and diabetes. For instance, according to Centers for Disease Control and Prevention (CDC), during July–December 2020, around 3.1% of adults aged 18 years had kidney disease. Chronic diseases such as diabetes, hypertension, and kidney diseases affect the urinary system, leading to changes in urine composition and color. As a result, urinalysis tests have become an essential diagnostic tool in the management of these chronic diseases. Therefore, the rise in prevalence of chronic diseases has increased the adoption of urinalysis tests to diagnose disease types, which propels the market growth.
In contrast, the limited awareness about the importance of urinalysis tests or lack of knowledge about collection of a urine sample, leading to inaccurate results impedes the growth of the market. In addition, many people in underdeveloped nations are not aware of the importance of urinalysis testing and do not understand the potential benefits of these tests, this could also limit the market growth.
Moreover, development and technological advancements in urinalysis testing provides growth opportunities in the emerging economies of Asia-Pacific and LAMEA regions during the forecast period. For instance, Mission U120 Urine Analyzer, a product of ACON Laboratories, Inc. company, has the capability of running up to 120 tests per hour and recalling 2,000 results. This enables a more accurate and comprehensive assessment of urine samples compared to traditional manual methods. Such technological advancements in urinalysis tests support the market growth.
In addition, there is a growing demand for point-of-care testing, which refers to diagnostic tests that can be performed near the patient's location. Urinalysis tests are often used as point-of-care tests, particularly in urgent care and emergency settings. The development of point-of-care urinalysis testing devices offers significant opportunities for growth and expansion of the urinalysis test market.
The global urinalysis test market is segmented into product, application, end user, and region. By product, the market is categorized into consumables and instruments. By application, the market is classified into disease screening and pregnancy & fertility. By end user, the market is classified into hospitals & clinics, diagnostic laboratories, and home care. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global urinalysis test market are Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., Bio-Rad Laboratories, Inc., Cardinal Health Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens AG, Sysmex Corporation, and 77 Elektronika Kft.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the urinalysis test market analysis from 2021 to 2031 to identify the prevailing urinalysis test market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the urinalysis test market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global urinalysis test market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
Instruments
Consumables
By Application
Disease screening
Pregnancy and fertility
By End user
Hospitals and clinics
Diagnostic laboratories
Home care
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Cardinal Health Inc.
Siemens AG
77 Elektronika Kft
ACON Laboratories, Inc.
Sysmex Corporation
Bio-Rad Laboratories, Inc.
ARKRAY, Inc.
Abbott Laboratories
Danaher Corporation
F. Hoffmann-La Roche Ltd.
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. Bargaining power of suppliers
- 3.3.2. Bargaining power of buyers
- 3.3.3. Threat of substitutes
- 3.3.4. Threat of new entrants
- 3.3.5. Intensity of rivalry
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Rise in prevalence of chronic diseases
- 3.4.1.2. Increase in the geriatric population
- 3.4.1.3. Increase in awareness about the importance of regular health checkups
- 3.4.2. Restraints
- 3.4.2.1. Lack of skilled laboratory technician
- 3.4.3. Opportunities
- 3.4.3.1. Technological innovations in urine analyzers
- 3.5. COVID-19 Impact Analysis on the market
- CHAPTER 4: URINALYSIS TEST MARKET, BY PRODUCT
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Instruments
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.3. Consumables
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- CHAPTER 5: URINALYSIS TEST MARKET, BY APPLICATION
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Disease screening
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Pregnancy and fertility
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- CHAPTER 6: URINALYSIS TEST MARKET, BY END USER
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Hospitals and clinics
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Diagnostic laboratories
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Home care
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- CHAPTER 7: URINALYSIS TEST MARKET, BY REGION
- 7.1. Overview
- 7.1.1. Market size and forecast By Region
- 7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Product
- 7.2.3. Market size and forecast, by Application
- 7.2.4. Market size and forecast, by End user
- 7.2.5. Market size and forecast, by country
- 7.2.5.1. U.S.
- 7.2.5.1.1. Key market trends, growth factors and opportunities
- 7.2.5.1.2. Market size and forecast, by Product
- 7.2.5.1.3. Market size and forecast, by Application
- 7.2.5.1.4. Market size and forecast, by End user
- 7.2.5.2. Canada
- 7.2.5.2.1. Key market trends, growth factors and opportunities
- 7.2.5.2.2. Market size and forecast, by Product
- 7.2.5.2.3. Market size and forecast, by Application
- 7.2.5.2.4. Market size and forecast, by End user
- 7.2.5.3. Mexico
- 7.2.5.3.1. Key market trends, growth factors and opportunities
- 7.2.5.3.2. Market size and forecast, by Product
- 7.2.5.3.3. Market size and forecast, by Application
- 7.2.5.3.4. Market size and forecast, by End user
- 7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Product
- 7.3.3. Market size and forecast, by Application
- 7.3.4. Market size and forecast, by End user
- 7.3.5. Market size and forecast, by country
- 7.3.5.1. Germany
- 7.3.5.1.1. Key market trends, growth factors and opportunities
- 7.3.5.1.2. Market size and forecast, by Product
- 7.3.5.1.3. Market size and forecast, by Application
- 7.3.5.1.4. Market size and forecast, by End user
- 7.3.5.2. France
- 7.3.5.2.1. Key market trends, growth factors and opportunities
- 7.3.5.2.2. Market size and forecast, by Product
- 7.3.5.2.3. Market size and forecast, by Application
- 7.3.5.2.4. Market size and forecast, by End user
- 7.3.5.3. UK
- 7.3.5.3.1. Key market trends, growth factors and opportunities
- 7.3.5.3.2. Market size and forecast, by Product
- 7.3.5.3.3. Market size and forecast, by Application
- 7.3.5.3.4. Market size and forecast, by End user
- 7.3.5.4. Italy
- 7.3.5.4.1. Key market trends, growth factors and opportunities
- 7.3.5.4.2. Market size and forecast, by Product
- 7.3.5.4.3. Market size and forecast, by Application
- 7.3.5.4.4. Market size and forecast, by End user
- 7.3.5.5. Spain
- 7.3.5.5.1. Key market trends, growth factors and opportunities
- 7.3.5.5.2. Market size and forecast, by Product
- 7.3.5.5.3. Market size and forecast, by Application
- 7.3.5.5.4. Market size and forecast, by End user
- 7.3.5.6. Rest of Europe
- 7.3.5.6.1. Key market trends, growth factors and opportunities
- 7.3.5.6.2. Market size and forecast, by Product
- 7.3.5.6.3. Market size and forecast, by Application
- 7.3.5.6.4. Market size and forecast, by End user
- 7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Product
- 7.4.3. Market size and forecast, by Application
- 7.4.4. Market size and forecast, by End user
- 7.4.5. Market size and forecast, by country
- 7.4.5.1. Japan
- 7.4.5.1.1. Key market trends, growth factors and opportunities
- 7.4.5.1.2. Market size and forecast, by Product
- 7.4.5.1.3. Market size and forecast, by Application
- 7.4.5.1.4. Market size and forecast, by End user
- 7.4.5.2. China
- 7.4.5.2.1. Key market trends, growth factors and opportunities
- 7.4.5.2.2. Market size and forecast, by Product
- 7.4.5.2.3. Market size and forecast, by Application
- 7.4.5.2.4. Market size and forecast, by End user
- 7.4.5.3. India
- 7.4.5.3.1. Key market trends, growth factors and opportunities
- 7.4.5.3.2. Market size and forecast, by Product
- 7.4.5.3.3. Market size and forecast, by Application
- 7.4.5.3.4. Market size and forecast, by End user
- 7.4.5.4. Australia
- 7.4.5.4.1. Key market trends, growth factors and opportunities
- 7.4.5.4.2. Market size and forecast, by Product
- 7.4.5.4.3. Market size and forecast, by Application
- 7.4.5.4.4. Market size and forecast, by End user
- 7.4.5.5. South Korea
- 7.4.5.5.1. Key market trends, growth factors and opportunities
- 7.4.5.5.2. Market size and forecast, by Product
- 7.4.5.5.3. Market size and forecast, by Application
- 7.4.5.5.4. Market size and forecast, by End user
- 7.4.5.6. Rest of Asia-Pacific
- 7.4.5.6.1. Key market trends, growth factors and opportunities
- 7.4.5.6.2. Market size and forecast, by Product
- 7.4.5.6.3. Market size and forecast, by Application
- 7.4.5.6.4. Market size and forecast, by End user
- 7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Product
- 7.5.3. Market size and forecast, by Application
- 7.5.4. Market size and forecast, by End user
- 7.5.5. Market size and forecast, by country
- 7.5.5.1. Brazil
- 7.5.5.1.1. Key market trends, growth factors and opportunities
- 7.5.5.1.2. Market size and forecast, by Product
- 7.5.5.1.3. Market size and forecast, by Application
- 7.5.5.1.4. Market size and forecast, by End user
- 7.5.5.2. Saudi Arabia
- 7.5.5.2.1. Key market trends, growth factors and opportunities
- 7.5.5.2.2. Market size and forecast, by Product
- 7.5.5.2.3. Market size and forecast, by Application
- 7.5.5.2.4. Market size and forecast, by End user
- 7.5.5.3. South Africa
- 7.5.5.3.1. Key market trends, growth factors and opportunities
- 7.5.5.3.2. Market size and forecast, by Product
- 7.5.5.3.3. Market size and forecast, by Application
- 7.5.5.3.4. Market size and forecast, by End user
- 7.5.5.4. Rest of LAMEA
- 7.5.5.4.1. Key market trends, growth factors and opportunities
- 7.5.5.4.2. Market size and forecast, by Product
- 7.5.5.4.3. Market size and forecast, by Application
- 7.5.5.4.4. Market size and forecast, by End user
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top player positioning, 2021
- CHAPTER 9: COMPANY PROFILES
- 9.1. ARKRAY, Inc.
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.2. Cardinal Health Inc.
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.3. Danaher Corporation
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
- 9.4. Siemens AG
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
- 9.5. Sysmex Corporation
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
- 9.5.7. Key strategic moves and developments
- 9.6. F. Hoffmann-La Roche Ltd.
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business performance
- 9.7. Bio-Rad Laboratories, Inc.
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.7.6. Business performance
- 9.8. ACON Laboratories, Inc.
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.9. 77 Elektronika Kft
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.10. Abbott Laboratories
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
- LIST OF TABLES
- TABLE 01. GLOBAL URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 02. URINALYSIS TEST MARKET FOR INSTRUMENTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 03. URINALYSIS TEST MARKET FOR CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
- TABLE 04. GLOBAL URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 05. URINALYSIS TEST MARKET FOR DISEASE SCREENING, BY REGION, 2021-2031 ($MILLION)
- TABLE 06. URINALYSIS TEST MARKET FOR PREGNANCY AND FERTILITY, BY REGION, 2021-2031 ($MILLION)
- TABLE 07. GLOBAL URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 08. URINALYSIS TEST MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 ($MILLION)
- TABLE 09. URINALYSIS TEST MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 10. URINALYSIS TEST MARKET FOR HOME CARE, BY REGION, 2021-2031 ($MILLION)
- TABLE 11. URINALYSIS TEST MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. NORTH AMERICA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 13. NORTH AMERICA URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 14. NORTH AMERICA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 15. NORTH AMERICA URINALYSIS TEST MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 16. U.S. URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 17. U.S. URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 18. U.S. URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 19. CANADA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 20. CANADA URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 21. CANADA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 22. MEXICO URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 23. MEXICO URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 24. MEXICO URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 25. EUROPE URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 26. EUROPE URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 27. EUROPE URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 28. EUROPE URINALYSIS TEST MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 29. GERMANY URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 30. GERMANY URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 31. GERMANY URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 32. FRANCE URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 33. FRANCE URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 34. FRANCE URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 35. UK URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 36. UK URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 37. UK URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 38. ITALY URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 39. ITALY URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 40. ITALY URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 41. SPAIN URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 42. SPAIN URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 43. SPAIN URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 44. REST OF EUROPE URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 45. REST OF EUROPE URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 46. REST OF EUROPE URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 47. ASIA-PACIFIC URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 48. ASIA-PACIFIC URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 49. ASIA-PACIFIC URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 50. ASIA-PACIFIC URINALYSIS TEST MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 51. JAPAN URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 52. JAPAN URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 53. JAPAN URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 54. CHINA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 55. CHINA URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 56. CHINA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 57. INDIA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 58. INDIA URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 59. INDIA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 60. AUSTRALIA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 61. AUSTRALIA URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 62. AUSTRALIA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 63. SOUTH KOREA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 64. SOUTH KOREA URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 65. SOUTH KOREA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 66. REST OF ASIA-PACIFIC URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 67. REST OF ASIA-PACIFIC URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 68. REST OF ASIA-PACIFIC URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 69. LAMEA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 70. LAMEA URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 71. LAMEA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 72. LAMEA URINALYSIS TEST MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 73. BRAZIL URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 74. BRAZIL URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 75. BRAZIL URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 76. SAUDI ARABIA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 77. SAUDI ARABIA URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 78. SAUDI ARABIA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 79. SOUTH AFRICA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 80. SOUTH AFRICA URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 81. SOUTH AFRICA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 82. REST OF LAMEA URINALYSIS TEST MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 83. REST OF LAMEA URINALYSIS TEST MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 84. REST OF LAMEA URINALYSIS TEST MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 85. ARKRAY, INC.: KEY EXECUTIVES
- TABLE 86. ARKRAY, INC.: COMPANY SNAPSHOT
- TABLE 87. ARKRAY, INC.: PRODUCT SEGMENTS
- TABLE 88. ARKRAY, INC.: PRODUCT PORTFOLIO
- TABLE 89. CARDINAL HEALTH INC.: KEY EXECUTIVES
- TABLE 90. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
- TABLE 91. CARDINAL HEALTH INC.: PRODUCT SEGMENTS
- TABLE 92. CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
- TABLE 93. DANAHER CORPORATION: KEY EXECUTIVES
- TABLE 94. DANAHER CORPORATION: COMPANY SNAPSHOT
- TABLE 95. DANAHER CORPORATION: PRODUCT SEGMENTS
- TABLE 96. DANAHER CORPORATION: PRODUCT PORTFOLIO
- TABLE 97. SIEMENS AG: KEY EXECUTIVES
- TABLE 98. SIEMENS AG: COMPANY SNAPSHOT
- TABLE 99. SIEMENS AG: PRODUCT SEGMENTS
- TABLE 100. SIEMENS AG: PRODUCT PORTFOLIO
- TABLE 101. SYSMEX CORPORATION: KEY EXECUTIVES
- TABLE 102. SYSMEX CORPORATION: COMPANY SNAPSHOT
- TABLE 103. SYSMEX CORPORATION: PRODUCT SEGMENTS
- TABLE 104. SYSMEX CORPORATION: PRODUCT PORTFOLIO
- TABLE 105. SYSMEX CORPORATION: KEY STRATERGIES
- TABLE 106. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
- TABLE 107. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
- TABLE 108. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
- TABLE 109. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
- TABLE 110. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
- TABLE 111. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
- TABLE 112. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
- TABLE 113. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
- TABLE 114. ACON LABORATORIES, INC.: KEY EXECUTIVES
- TABLE 115. ACON LABORATORIES, INC.: COMPANY SNAPSHOT
- TABLE 116. ACON LABORATORIES, INC.: PRODUCT SEGMENTS
- TABLE 117. ACON LABORATORIES, INC.: PRODUCT PORTFOLIO
- TABLE 118. 77 ELEKTRONIKA KFT: KEY EXECUTIVES
- TABLE 119. 77 ELEKTRONIKA KFT: COMPANY SNAPSHOT
- TABLE 120. 77 ELEKTRONIKA KFT: PRODUCT SEGMENTS
- TABLE 121. 77 ELEKTRONIKA KFT: PRODUCT PORTFOLIO
- TABLE 122. ABBOTT LABORATORIES: KEY EXECUTIVES
- TABLE 123. ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 124. ABBOTT LABORATORIES: PRODUCT SEGMENTS
- TABLE 125. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- LIST OF FIGURES
- FIGURE 01. URINALYSIS TEST MARKET, 2021-2031
- FIGURE 02. SEGMENTATION OF URINALYSIS TEST MARKET, 2021-2031
- FIGURE 03. TOP INVESTMENT POCKETS IN URINALYSIS TEST MARKET (2022-2031)
- FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 06. MODERATE THREAT OF SUBSTITUTES
- FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 08. MODERATE INTENSITY OF RIVALRY
- FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALURINALYSIS TEST MARKET
- FIGURE 10. URINALYSIS TEST MARKET, BY PRODUCT, 2021(%)
- FIGURE 11. COMPARATIVE SHARE ANALYSIS OF URINALYSIS TEST MARKET FOR INSTRUMENTS, BY COUNTRY 2021 AND 2031(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF URINALYSIS TEST MARKET FOR CONSUMABLES, BY COUNTRY 2021 AND 2031(%)
- FIGURE 13. URINALYSIS TEST MARKET, BY APPLICATION, 2021(%)
- FIGURE 14. COMPARATIVE SHARE ANALYSIS OF URINALYSIS TEST MARKET FOR DISEASE SCREENING, BY COUNTRY 2021 AND 2031(%)
- FIGURE 15. COMPARATIVE SHARE ANALYSIS OF URINALYSIS TEST MARKET FOR PREGNANCY AND FERTILITY, BY COUNTRY 2021 AND 2031(%)
- FIGURE 16. URINALYSIS TEST MARKET, BY END USER, 2021(%)
- FIGURE 17. COMPARATIVE SHARE ANALYSIS OF URINALYSIS TEST MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY 2021 AND 2031(%)
- FIGURE 18. COMPARATIVE SHARE ANALYSIS OF URINALYSIS TEST MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY 2021 AND 2031(%)
- FIGURE 19. COMPARATIVE SHARE ANALYSIS OF URINALYSIS TEST MARKET FOR HOME CARE, BY COUNTRY 2021 AND 2031(%)
- FIGURE 20. URINALYSIS TEST MARKET BY REGION, 2021
- FIGURE 21. U.S. URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 22. CANADA URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 23. MEXICO URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 24. GERMANY URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 25. FRANCE URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 26. UK URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 27. ITALY URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 28. SPAIN URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 29. REST OF EUROPE URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 30. JAPAN URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 31. CHINA URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 32. INDIA URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 33. AUSTRALIA URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 34. SOUTH KOREA URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 35. REST OF ASIA-PACIFIC URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 36. BRAZIL URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 37. SAUDI ARABIA URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 38. SOUTH AFRICA URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 39. REST OF LAMEA URINALYSIS TEST MARKET, 2021-2031 ($MILLION)
- FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 44. COMPETITIVE DASHBOARD
- FIGURE 45. COMPETITIVE HEATMAP: URINALYSIS TEST MARKET
- FIGURE 46. TOP PLAYER POSITIONING, 2021
- FIGURE 47. CARDINAL HEALTH INC.: NET REVENUE, 2020-2022 ($MILLION)
- FIGURE 48. CARDINAL HEALTH INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 49. CARDINAL HEALTH INC.: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 50. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
- FIGURE 51. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 52. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 53. SIEMENS: NET REVENUE, 2019-2021 ($MILLION)
- FIGURE 54. SIEMENS: REVENUE SHARE BY SEGMENT, 2021 (%)
- FIGURE 55. SIEMENS: REVENUE SHARE BY REGION, 2021 (%)
- FIGURE 56. SYSMEX CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
- FIGURE 57. SYSMEX CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
- FIGURE 58. F. HOFFMANN-LA ROCHE LTD.: NET SALES, 2020-2022 ($MILLION)
- FIGURE 59. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 60. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 61. BIO-RAD LABORATORIES, INC. : NET SALES, 2020-2022 ($MILLION)
- FIGURE 62. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 63. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 64. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
- FIGURE 65. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 66. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook